Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients.
作者信息
Chojnacki M, Kralik P, Allen R H, Ho B T, Schoolar J C, Smith R C
出版信息
Am J Psychiatry. 1981 Jun;138(6):838-40. doi: 10.1176/ajp.138.6.838.
PMID:6113772
Abstract
摘要
相似文献
1
Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients.
Am J Psychiatry. 1981 Jun;138(6):838-40. doi: 10.1176/ajp.138.6.838.
2
Effects of neuroleptics on platelet monoamine oxidase activity.
Biol Psychiatry. 1982 Aug;17(8):885-95.
3
Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Encephale. 1985 Jan-Feb;11(1):31-4.
4
A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
Psychiatry Res. 1981 Feb;4(1):95-107. doi: 10.1016/0165-1781(81)90013-5.
5
Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.
Nature. 1972 Jul 28;238(5361):225-6. doi: 10.1038/238225a0.
6
Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Psychiatry Res. 1982 Oct;7(2):179-87. doi: 10.1016/0165-1781(92)90091-g.
7
Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
Folia Psychiatr Neurol Jpn. 1975;29(3):207-14. doi: 10.1111/j.1440-1819.1975.tb02337.x.
8
Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
Am J Psychiatry. 1982 Oct;139(10):1242-8. doi: 10.1176/ajp.139.10.1242.
9
Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
Br J Psychiatry. 1979 Apr;134:366-71.
10
Platelet monoamine oxidase in schizophrenia: a meta-analysis.
Schizophr Res. 1992 Sep;7(3):249-67. doi: 10.1016/0920-9964(92)90019-2.
引用本文的文献
1
Monoamine oxidase gene transcription in human cell lines: treatment with psychoactive drugs and ethanol.
J Neural Transm (Vienna). 1996;103(6):681-92. doi: 10.1007/BF01271228.
2
Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.
Psychopharmacology (Berl). 1995 Mar;118(2):206-12. doi: 10.1007/BF02245841.
3
Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
Psychopharmacology (Berl). 1983;79(2-3):177-9. doi: 10.1007/BF00427807.
4
Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?
Eur Arch Psychiatry Neurol Sci. 1987;237(1):8-15. doi: 10.1007/BF00385661.
Zotero 插件